Search

everythinglearnresearchcommunity

for

Search:↓

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Tofacitinib and methotrexate successfully treated a woman's severe skin, joint, and hair loss issues.

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

A man with Acrodermatitis continua did not get better with etanercept treatment, and his condition worsened, suggesting treatment effectiveness may vary by genetics and race.

Acitretin treats severe skin conditions but requires careful monitoring due to serious side effects.

Tofacitinib effectively treats severe alopecia areata, improving hair regrowth and patient satisfaction.

Topical tofacitinib is effective and safe for treating alopecia areata.

Topical tacalcitol ointment can help improve symptoms of EFFC.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

The combination treatment showed a higher response rate but no significant survival benefits.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Tofacitinib was found to be a safe and effective treatment for hair regrowth in patients with alopecia areata.